Our results corroborate that blood pressure, anthropometric measurements, leptin, adiponectin, and ALT differ in NAFLD individuals compared to subjects without NAFLD, as found in previous studies [16,40,41], even when adjusting by BMI. The gene discussed is LEP; the disease is metabolic dysfunction-associated steatotic liver disease.